top of page
Search


Artificial intelligence to Control acute pulmonary Exacerbations in Cystic Fibrosis
Artificial intelligence to Control acute pulmonary Exacerbations in Cystic Fibrosis
Glenn Hearson
Jul 24, 2024


EXHALE-2 Study to assess the efficacy, safety, and tolerability of dexpramipexole in participants with severe eosinophilic asthma
EXHALE-2 Study to assess the efficacy, safety, and tolerability of dexpramipexole in participants with severe eosinophilic asthma
Glenn Hearson
Jul 24, 2024


Non-invasive Monitoring for non-invasive ventilation: Use of transcutaneous carbon dioxide monitoring: The REACT-CO2 Study
We have recently commenced a new randomised clinical trial led by Dr Milind Sovani at NUH with funding from Radiometer using a skin...
Glenn Hearson
Jan 5, 2024


Physiological and environmental data in a remote setting to predict exacerbation events in COPD
We have recently commenced a new study, led at Nottingham University Hospital NHS Trust by Dr Matthew Martin, to monitor around 300...
Glenn Hearson
Nov 17, 2023


C-FIND COPD Study Featured on BBC Radio Nottingham Sarah Julian Show
Thanks to @BBCNottingham and @mariarubiomedia for joining us today at our mobile research unit at Morrisons supermarket in Clifton...
Glenn Hearson
Nov 10, 2023


Continuous respiratory rate and pulse oximetry monitoring using wearable sensors (RespiraSense)
We have recently commenced a new clinical trial testing a new device called RespiraSense which is worn on a patients chest and measures...
Glenn Hearson
Sep 6, 2023


COPD Case Finding In Nottingham and District: C-FIND COPD A Pilot study
We have now commenced a new research study supported by the NIHR Nottingham Biomedical Research Centre , NIHR Nottingham Clinical...
Glenn Hearson
Aug 21, 2023


Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole
We have just commenced recruiting patients into a new trial which funded by an NIHR HTA Grant with Chief Investigator Professor Andrew...
Glenn Hearson
May 25, 2023
bottom of page
